查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585656

生物製藥發酵系統市場：按產品、應用和最終用戶分類 - 全球預測 2025-2030

Biopharmaceutical Fermentation System Market by Product (Downstream Process Product, Upstream Process Product), Application (Antibiotics, Monoclonal Antibodies, Probiotics), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年生物製藥發酵系統市值為156.5億美元，預計2024年將達到168.6億美元，複合年成長率為7.82%，預計到2030年將達到265.2億美元。

生物製藥發酵系統市場主要包括透過微生物和細胞發酵製程生產生物製藥的技術和設備。透過促進受控微生物生長，這些系統對於大規模生產生技藥品（包括疫苗、單株抗體和重組蛋白）至關重要。發酵系統在生產無法化學合成的複雜生物活性產品方面發揮關鍵作用，凸顯了對發酵系統的需求。應用包括製藥、生物技術、食品和飲料以及環境，最終用戶範圍從製藥公司到受託製造廠商和研究機構。影響該市場的主要成長要素包括由於慢性病的增加而對生物製藥的需求不斷增加以及對個人化醫療的興趣日益濃厚。生物製程設備的技術進步以及一次性系統的創新也透過提供更靈活、更具成本效益和擴充性的解決方案來推動市場成長。最新的潛在商機存在於醫療保健基礎設施正在發展的新興市場以及新型生物相似藥和生技藥品的開拓中市場。然而，高昂的初始資本投資、嚴格的監管要求和複雜的製造流程等挑戰嚴重限制了市場擴張。需要創新的領域包括開發高效的下游加工技術、改進過程分析技術（PAT）以及透過合成生物學提高生物製藥生產的效率。探索發酵過程的自動化和數位化也為業務成長提供了途徑。該市場是動態的，其特點是技術快速進步和競爭格局，主要企業在研發方面投入大量資金。隨著產業轉向更綠色的生物製造實踐，公司可以透過專注於開發更永續和更有效率的發酵過程來利用這些趨勢。

主要市場統計
基準年[2023] 156.5億美元
預測年份 [2024] 168.6億美元
預測年份 [2030] 265.2億美元
複合年成長率（%） 7.82%

市場動態：快速發展的生物製藥發酵系統市場的關鍵市場洞察

供需的動態交互作用正在改變生物製藥發酵系統市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 生物製藥需求不斷成長
    • 慢性病增加
    • 生物基生產過程中工業測量與監控技術的發展
  • 市場限制因素
    • 與製造業相關的高成本和嚴格的監管要求
  • 市場機會
    • 創造高效且經濟高效的發酵系統的新創新
    • 發酵技術各領域研發的活性化
  • 市場挑戰
    • 缺乏對生物製藥發酵系統的認知和訓練有素的專業人員

波特五力：駕馭生物製藥發酵系統市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解生物製藥發酵系統市場的外部影響

外部宏觀環境因素在塑造生物製藥發酵系統市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解生物製藥發酵系統市場的競爭格局

對生物製藥發酵系統市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣生物製藥發酵系統市場供應商績效評估

FPNV定位矩陣是評估生物製藥發酵系統市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了生物製藥發酵系統市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對生物製藥發酵系統市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對生物技術藥物的需求增加
      • 慢性病發生率增加
      • 生物基生產過程的工業測量和監控技術的開發
    • 抑制因素
      • 與製造業相關的高成本和嚴格的監管要求
    • 機會
      • 高效且經濟高效的發酵系統的新創新
      • 增加發酵技術各領域的研發活動
    • 任務
      • 對生物製藥發酵系統的認知有限且訓練有素的專家
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章生物製藥發酵系統市場：依產品

  • 下游加工產品
    • 層析法系統
    • 耗材及配件
    • 過濾/分離設備
  • 上游製程產品
    • 反應器或發酵罐
    • 緩衝
    • 媒體和文化準備
    • 過程監控系統

第7章生物製藥發酵系統市場：依應用分類

  • 抗生素
  • 單株抗體
  • 益生菌
  • 重組蛋白

第8章生物製藥發酵系統市場：依最終用戶分類

  • 生物製藥公司
  • 合約調查機構
  • 食品工業
  • 研發機構

第9章美洲生物製藥發酵系統市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太生物製藥發酵系統市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲生物製藥發酵系統市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Agilent Technologies, Inc.
  • AntoXa Corporation
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioPharm Process Associates, LLC
  • Danaher Corporation
  • Eppendorf SE
  • F. Hoffmann-La Roche AG
  • GEA Group Aktiengesellschaft
  • General Electric Company
  • Lonza Group
  • Merck KGaA
  • Nova Biomedical Corporation
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
  • ZETA GmbH
Product Code: MRR-437D45957C17

The Biopharmaceutical Fermentation System Market was valued at USD 15.65 billion in 2023, expected to reach USD 16.86 billion in 2024, and is projected to grow at a CAGR of 7.82%, to USD 26.52 billion by 2030.

The biopharmaceutical fermentation system market encompasses technologies and equipment used in the production of biopharmaceuticals, primarily through microbial and cell-based fermentation processes. These systems are essential for the large-scale production of biologics, including vaccines, monoclonal antibodies, and recombinant proteins, by facilitating controlled microbial growth. The necessity of fermentation systems is underscored by their critical role in producing complex, biologically active products that cannot be synthesized chemically. Applications include pharmaceuticals, biotechnology, food & beverages, and the environment, with end-users spanning from pharmaceutical companies to contract manufacturing organizations and research institutes. Key growth factors influencing this market include the rising demand for biopharmaceuticals due to increasing instances of chronic diseases and a growing focus on personalized medicine. Technological advancements in bioprocessing equipment, along with innovations in single-use systems, have also propelled market growth by offering more flexible, cost-effective, and scalable solutions. The latest potential opportunities lie in emerging markets with growing healthcare infrastructures and in the development of novel biosimilars and biologics. However, challenges such as high initial capital investment, stringent regulatory requirements, and complex manufacturing processes pose significant limitations to market expansion. Areas ripe for innovation include the development of efficient downstream processing techniques, improvements in process analytical technologies (PAT), and advancements in biologic production efficiency through synthetic biology. Research into automation and digitalization within fermentation processes also offers pathways for business growth. The market is dynamic, characterized by rapid technological advancements and a competitive landscape with key players investing heavily in R&D. Businesses can capitalize on these trends by focusing on developing more sustainable and efficient fermentation processes, thereby aligning with the industry's shift toward more eco-friendly biomanufacturing practices.

KEY MARKET STATISTICS
Base Year [2023] USD 15.65 billion
Estimated Year [2024] USD 16.86 billion
Forecast Year [2030] USD 26.52 billion
CAGR (%) 7.82%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biopharmaceutical Fermentation System Market

The Biopharmaceutical Fermentation System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing demand for biotech based drugs
    • Increasing incidences of chronic diseases
    • Development in industrial measurement and monitoring technologies for bio-based production processes
  • Market Restraints
    • High cost related with the manufacturing and stringent regulatory requirements
  • Market Opportunities
    • New innovations to make efficient and cost-effective fermentation systems
    • Increasing research and developmental activities in different fields of fermentation technology
  • Market Challenges
    • Limited awareness and trained professionals in the field for biopharmaceutical fermentation systems

Porter's Five Forces: A Strategic Tool for Navigating the Biopharmaceutical Fermentation System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biopharmaceutical Fermentation System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biopharmaceutical Fermentation System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biopharmaceutical Fermentation System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biopharmaceutical Fermentation System Market

A detailed market share analysis in the Biopharmaceutical Fermentation System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biopharmaceutical Fermentation System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biopharmaceutical Fermentation System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biopharmaceutical Fermentation System Market

A strategic analysis of the Biopharmaceutical Fermentation System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biopharmaceutical Fermentation System Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., AntoXa Corporation, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BioPharm Process Associates, LLC, Danaher Corporation, Eppendorf SE, F. Hoffmann-La Roche AG, GEA Group Aktiengesellschaft, General Electric Company, Lonza Group, Merck KGaA, Nova Biomedical Corporation, Sartorius AG, Thermo Fisher Scientific Inc., and ZETA GmbH.

Market Segmentation & Coverage

This research report categorizes the Biopharmaceutical Fermentation System Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Downstream Process Product and Upstream Process Product. The Downstream Process Product is further studied across Chromatography Systems, Consumables & Accessories, and Filtration & Separation Instruments. The Upstream Process Product is further studied across Bioreactors or Fermenters, Buffers, Media & Culture Preparation, and Process Monitoring Systems.
  • Based on Application, market is studied across Antibiotics, Monoclonal Antibodies, Probiotics, and Recombinant Proteins.
  • Based on End User, market is studied across Biopharmaceutical Companies, Contract Research Organizations, Food Industry, and Research & Development Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for biotech based drugs
      • 5.1.1.2. Increasing incidences of chronic diseases
      • 5.1.1.3. Development in industrial measurement and monitoring technologies for bio-based production processes
    • 5.1.2. Restraints
      • 5.1.2.1. High cost related with the manufacturing and stringent regulatory requirements
    • 5.1.3. Opportunities
      • 5.1.3.1. New innovations to make efficient and cost-effective fermentation systems
      • 5.1.3.2. Increasing research and developmental activities in different fields of fermentation technology
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness and trained professionals in the field for biopharmaceutical fermentation systems
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biopharmaceutical Fermentation System Market, by Product

  • 6.1. Introduction
  • 6.2. Downstream Process Product
    • 6.2.1. Chromatography Systems
    • 6.2.2. Consumables & Accessories
    • 6.2.3. Filtration & Separation Instruments
  • 6.3. Upstream Process Product
    • 6.3.1. Bioreactors or Fermenters
    • 6.3.2. Buffers
    • 6.3.3. Media & Culture Preparation
    • 6.3.4. Process Monitoring Systems

7. Biopharmaceutical Fermentation System Market, by Application

  • 7.1. Introduction
  • 7.2. Antibiotics
  • 7.3. Monoclonal Antibodies
  • 7.4. Probiotics
  • 7.5. Recombinant Proteins

8. Biopharmaceutical Fermentation System Market, by End User

  • 8.1. Introduction
  • 8.2. Biopharmaceutical Companies
  • 8.3. Contract Research Organizations
  • 8.4. Food Industry
  • 8.5. Research & Development Institutes

9. Americas Biopharmaceutical Fermentation System Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Biopharmaceutical Fermentation System Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Biopharmaceutical Fermentation System Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. AntoXa Corporation
  • 3. Becton, Dickinson and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. BioPharm Process Associates, LLC
  • 6. Danaher Corporation
  • 7. Eppendorf SE
  • 8. F. Hoffmann-La Roche AG
  • 9. GEA Group Aktiengesellschaft
  • 10. General Electric Company
  • 11. Lonza Group
  • 12. Merck KGaA
  • 13. Nova Biomedical Corporation
  • 14. Sartorius AG
  • 15. Thermo Fisher Scientific Inc.
  • 16. ZETA GmbH

LIST OF FIGURES

  • FIGURE 1. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY CONSUMABLES & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY FILTRATION & SEPARATION INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY BIOREACTORS OR FERMENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY BUFFERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY MEDIA & CULTURE PREPARATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PROCESS MONITORING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY FOOD INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY RESEARCH & DEVELOPMENT INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 238. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023